Back to search results

Investigating Outcomes of Robotic Transhiatal Esophagectomy

This study is looking at the health outcomes of adult patients (18 to 89 years old) who have undergone or will undergo an elective robotic transhiatal esophagectomy. This is a surgery where all or part of your esophagus (the tube that carries food from your mouth to your stomach) is removed. The researchers want to understand the impact of this surgery on your health after the procedure. They will collect information from your medical records before, during, and after your surgery. The main things they are looking for are complications like anastomotic leak (a leak where parts of your digestive system are reconnected), esophageal stricture (narrowing of the esophagus), and pneumonia, all measured within the first three months after surgery. You can join if you are an adult undergoing this surgery or have already had it and can provide consent.

Study design
This is an observational study, meaning researchers will collect information about patients who have had or will have this surgery. The study plans to include 120 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will track certain health outcomes for the first three months after your surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05950438

Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy

Recruiting
Not specifiedAges 18–89Observational
Northwestern University
~120 participants
Updated 2026-05-26 on ClinicalTrials.gov
What's tested:Esophagectomy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of Participants with Anastomotic Leak
Measured over During first 3 months postop
+20 more outcomes measured

Conditions

Esophagectomy

Explore related trials

Esophageal Disorder

Where it's being run

1 sites across 1 states
Illinois1

Study leadership

  • Ankit Bharat, MD · PRINCIPAL_INVESTIGATOR · Northwestern University

Who to contact

Ankit Bharat, MD
[email protected]
312-926-7628
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adult patients (18 years or older)
Patients undergoing elective esophagectomy for any indication
Patients who have already had an elective esophagectomy for any indication
Patients with consent providing capacity

Exclusion

Patients undergoing emergent esophagectomy
Adults unable to consent
Individuals who are not yet adults (infants, children, teenagers)
Pregnant women
Prisoners
Vulnerable Populations

What this trial measures

  • Number of Participants with Anastomotic LeakDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with Esophageal StrictureDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with PneumoniaDuring first 3 months postop

    Postoperative Complication

  • Number of Participants Requiring Ventilation >48 HoursDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with EmpyemaDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with Pulmonary EmbolismDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with Deep Venous ThrombosisDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with Gastric Outlet ObstructionDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with StrokeDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with Atrial FibrillationDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with Vocal Cord ParalysisDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with Myocardial InfarctionDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with ChylothoraxDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with Acute Renal InjuryDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with Wound InfectionsDuring first 3 months postop

    Postoperative Complication

  • Rates of Re-operationDuring first 3 months postop

    Postoperative Complication

  • Rates of Re-AdmissionDuring first 3 months postop

    Postoperative Complication

  • Number of Participants with Intensive Care Unit (ICU) StayDuring first 3 months postop

    Postoperative Complication

  • Rates of Length of Hospital StayPostoperative

    Postoperative Complication

  • Rates of 30-day SurvivalPostoperative

    Postoperative Complication

  • Rates of 90-day Survival RatesPostoperative

    Postoperative Complication